中华内分泌代谢杂志
中華內分泌代謝雜誌
중화내분비대사잡지
CHINESE JOURNAL OF ENDOCRINOLOGY AND METABOLISM
2011年
8期
641-643
,共3页
谢莹%尤寿江%严茹红%曹勇军%张艳林%董吉祥%刘春风
謝瑩%尤壽江%嚴茹紅%曹勇軍%張豔林%董吉祥%劉春風
사형%우수강%엄여홍%조용군%장염림%동길상%류춘풍
血管内皮细胞钙黏蛋白%糖基化终产物,晚期%糖尿病%动脉粥样硬化
血管內皮細胞鈣黏蛋白%糖基化終產物,晚期%糖尿病%動脈粥樣硬化
혈관내피세포개점단백%당기화종산물,만기%당뇨병%동맥죽양경화
Vascular endothelial cells cadherin%Glycation end-products,advanced%Diabetes mellitus%Atherosclerosis
研究糖尿病患者血清血管内皮细胞钙黏蛋白(VE-cadherin)、晚期糖基化终产物(AGE)与糖尿病大血管病变的关系.设健康对照组20例,糖尿病患者60例,其中伴颈动脉粥样硬化组30例,采用ELISA法测定各组血清可溶性VE-cadherin、AGE,并与病程、血糖水平进行多元逐步回归分析.糖尿病组与颈动脉粥样硬化组的VE-cadherin、AGE水平均高于对照组(均P<0.05),糖尿病组与颈动脉粥样硬化组之间VE-cadherin差异有统计学意义(P<0.05).VE-cadherin水平与AGE显著正相关(r=0.69,P<0.01),AGE与糖尿病病程呈正相关(r=0.31,P=0.02).糖尿病患者血清中可溶性VE-cadherin水平与AGE相关,推测VE-cadherin可能是AGE致动脉粥样硬化的靶点和重要环节.
研究糖尿病患者血清血管內皮細胞鈣黏蛋白(VE-cadherin)、晚期糖基化終產物(AGE)與糖尿病大血管病變的關繫.設健康對照組20例,糖尿病患者60例,其中伴頸動脈粥樣硬化組30例,採用ELISA法測定各組血清可溶性VE-cadherin、AGE,併與病程、血糖水平進行多元逐步迴歸分析.糖尿病組與頸動脈粥樣硬化組的VE-cadherin、AGE水平均高于對照組(均P<0.05),糖尿病組與頸動脈粥樣硬化組之間VE-cadherin差異有統計學意義(P<0.05).VE-cadherin水平與AGE顯著正相關(r=0.69,P<0.01),AGE與糖尿病病程呈正相關(r=0.31,P=0.02).糖尿病患者血清中可溶性VE-cadherin水平與AGE相關,推測VE-cadherin可能是AGE緻動脈粥樣硬化的靶點和重要環節.
연구당뇨병환자혈청혈관내피세포개점단백(VE-cadherin)、만기당기화종산물(AGE)여당뇨병대혈관병변적관계.설건강대조조20례,당뇨병환자60례,기중반경동맥죽양경화조30례,채용ELISA법측정각조혈청가용성VE-cadherin、AGE,병여병정、혈당수평진행다원축보회귀분석.당뇨병조여경동맥죽양경화조적VE-cadherin、AGE수평균고우대조조(균P<0.05),당뇨병조여경동맥죽양경화조지간VE-cadherin차이유통계학의의(P<0.05).VE-cadherin수평여AGE현저정상관(r=0.69,P<0.01),AGE여당뇨병병정정정상관(r=0.31,P=0.02).당뇨병환자혈청중가용성VE-cadherin수평여AGE상관,추측VE-cadherin가능시AGE치동맥죽양경화적파점화중요배절.
To investigate the relationship among serum vascular endothelial cells(VE) -cadherin, advanced glycation end-products( AGE), and atherosclerotic lesion. 20 healthy subjects and 60 patients with diabetes mellitus,including 30 patients with carotid atherosclerosis (CI), were enrolled. Soluble VE-cadherin and AGE were determined using the enzyme-linked immunosorbent method (ELISA). The relationships among the concentration of soluble VE-cadherin, AGE, and the course of the disease, blood glucose, and blood lipid levels were analyzed with multivariant stepwise regression analysis. The levels of serum VE-cadherin and AGE in the patients with diabetes and CI were higher than those in control group( P<0. 05 ). There was a significant difference in VE-cadherin between the diabetes group and the CI group( P<0. 05 ). Serum VE-cadherin levels were positively correlated with serum AGE levels(r = 0. 69, P<0. 01 ). AGE levels were positively correlated with the diabetes duration ( r = 0. 31, P =0. 02 ). The levels of serum VE-cadherin in diabetic patients are positively correlated with their serum AGE levels. The VE-cadherin seems to play an important role in the development of atherosclerosis caused by AGE.